로딩 중…
StockDiggingStockDigging

DongBang Medical

240550· KOSDAQ
₩5,790+6.43%
2026-08-04

Financials

Valuation Metrics

DongBang Medical's Market Cap is ₩1212B. At end of 2025 it was ₩1635B. Ranked #1104 of 2,436 in KR market (top 45%), #569 of 1,649 on KOSDAQ (top 35%), #39 of 96 in Health Care Equipment & Services (top 41%) by Market Cap.

Investment Metrics(as of 2026-08-04)

MetricValue
Size
Market Cap121.21B KRW
Revenue117.37B KRW
Net Income13.55B KRW
Total Assets190.76B KRW
Net Assets133.00B KRW
Employees284
Value
P/E8.95x
P/B0.91x
PEG0.13x
P/S1.03x
EV/EBITDA6.73x
Profitability
ROE10.19%
ROA7.10%
Op. Margin16.00%
Revenue Growth13.90%
Earnings Growth66.37%
Financial Health
Debt Ratio143.43%
Total Debt31.42B KRW
Cash26.16B KRW
Current Ratio2.31x
Net Debt/EBITDA0.28x
Performance
1Y Return-46.49%
1M Return-1.70%
From 52W High-53.04%
1Y MDD-64.60%
Trading
Volume65,859 shares
Foreign Own.3.24%
Per Share
EPS669 KRW
BPS6,240 KRW

Company Info

CEO 최낙이
Employees 284
Founded 2014
HQ 충청남도 보령시, KR

Dongbang Medical, established in 1985 and converted into a corporation in 2014, listed on the KOSDAQ market in 2025. The company primarily focuses on manufacturing and selling traditional Korean medicine medical devices and aesthetic medical devices, achieving the top domestic market share in disposable traditional Korean medicine acupuncture needles and disposable cupping cups. Leveraging its automated production system and excellent technology, it exports products globally and continuously conducts R&D for product improvement and new market entry. It is headquartered in Boryeong-si, Chungcheongnam-do.